Vista Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024, to consider and approve Un Audited financial results for the quarter ended 30.06.2024; Limited Review Report for quarter ended 30.06.2024; and any other business with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.